Dr. Cochran serves as the Director of the neuropathology and autopsy services of the Medical College of Wisconsin Department of Pathology and Froedtert Hospital.
She also directs medical student Education in Pathology, including pathology clerkships for third and fourth year medical students of the Medical College of Wisconsin.
Chang JC, Harrington AM, Olteanu H, VanTuinen P, Kroft SH.
Proliferation centers in bone marrows involved by chronic lymphocytic leukemia/small lymphocytic lymphoma: a clinicopathologic analysis.Ann Diagn Pathol 2016 Dec;25:15-19
Harrington AM, Schelling LA, Ordobazari A, Olteanu H, Hosking PR, Kroft SH.
Immunophenotypes of Chronic Myelomonocytic Leukemia (CMML) Subtypes by Flow Cytometry: A Comparison of CMML-1 vs CMML-2, Myeloproliferative vs Dysplastic, De Novo vs Therapy-Related, and CMML-Specific Cytogenetic Risk Subtypes.Am J Clin Pathol 2016 Aug;146(2):170-81
Li H, Hasserjian RP, Kroft SH, Harrington AM, Wheaton SE, Pildain A, Ewalt MD, Gratzinger D, Hosking P, Olteanu H.
Pure Erythroid Leukemia and Erythroblastic Sarcoma Evolving From Chronic Myeloid Neoplasms.Am J Clin Pathol 2016 Apr;145(4):538-51
Cogbill CH, Spears MD, Vantuinen P, Harrington AM, Olteanu H, Kroft SH.
Morphologic and cytogenetic variables affect the flow cytometric recovery of plasma cell myeloma cells in bone marrow aspirates.Int J Lab Hematol 2015 Dec;37(6):797-808
Olteanu H, Harrington AM, Kroft SH.
CD200 expression in plasma cells of nonmyeloma immunoproliferative disorders: clinicopathologic features and comparison with plasma cell myeloma.Am J Clin Pathol 2012 ;2(2):128-35
Olteanu H, Schur BC, Harrington AM, Kroft SH.
Time and temperature stability of T-cell subsets evaluated by a dual-platform method.Am J Blood Res 2012 ;2(2):128-35
